These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34981659)

  • 21. Trafficking mechanism of bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma HepG2 cells by modulating Endoglin, CXCR4 and TGF-β.
    Mardomi A; Sabzichi M; Hussein Somi M; Shanehbandi D; Rahbarghazi R; Taj Sanjarani O; Samadi N
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):81-86. PubMed ID: 27755957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 23. Mesenchymal stem cell therapy of hepatocellular carcinoma in rats: Detection of cell homing and tumor mass by magnetic resonance imaging using iron oxide nanoparticles.
    Faidah M; Noorwali A; Atta H; Ahmed N; Habib H; Damiati L; Filimban N; Al-Qriqri M; Mahfouz S; Khabaz MN
    Adv Clin Exp Med; 2017 Nov; 26(8):1171-1178. PubMed ID: 29264872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation.
    Wu N; Zhang YL; Wang HT; Li DW; Dai HJ; Zhang QQ; Zhang J; Ma Y; Xia Q; Bian JM; Hang HL
    Cancer Biol Ther; 2016 May; 17(5):558-65. PubMed ID: 27124543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma.
    Xu Y; Liao W; Luo Q; Yang D; Pan M
    Front Immunol; 2022; 13():761046. PubMed ID: 35145517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
    Alshareeda AT; Sakaguchi K; Abumaree M; Mohd Zin NK; Shimizu T
    PLoS One; 2017; 12(8):e0184004. PubMed ID: 28850615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
    Mi F; Gong L
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis.
    Zhang LN; Zhang DD; Yang L; Gu YX; Zuo QP; Wang HY; Xu J; Liu DX
    FEBS J; 2021 Mar; 288(5):1447-1456. PubMed ID: 33070450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
    Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distinct roles of mesenchymal stem cells in the initial and progressive stage of hepatocarcinoma.
    Zong C; Zhang H; Yang X; Gao L; Hou J; Ye F; Jiang J; Yang Y; Li R; Han Z; Wei L
    Cell Death Dis; 2018 Mar; 9(3):345. PubMed ID: 29497038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.
    Bayo J; Fiore E; Aquino JB; Malvicini M; Rizzo M; Peixoto E; Alaniz L; Piccioni F; Bolontrade M; Podhajcer O; Garcia MG; Mazzolini G
    Biomed Res Int; 2014; 2014():837420. PubMed ID: 25147818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition.
    Jing Y; Han Z; Liu Y; Sun K; Zhang S; Jiang G; Li R; Gao L; Zhao X; Wu D; Cai X; Wu M; Wei L
    PLoS One; 2012; 7(8):e43272. PubMed ID: 22952657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
    Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
    J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistent Inclusion of Mesenchymal Stem Cells into In Vitro Tumor Models.
    Ferreira LP; Gaspar VM; Mano JF
    Methods Mol Biol; 2021; 2269():3-23. PubMed ID: 33687668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
    Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
    Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling.
    Abdel aziz MT; El Asmar MF; Atta HM; Mahfouz S; Fouad HH; Roshdy NK; Rashed LA; Sabry D; Hassouna AA; Taha FM
    J Exp Clin Cancer Res; 2011 May; 30(1):49. PubMed ID: 21545718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
    Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.